Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

VCH-916 free acid(1200133-34-1 free base)

Copy Product Info
🥰Excellent
Catalog No. TQ0122LCas No. 914778-92-0

VCH-916 is a novel nonnucleoside HCV NS5B polymerase inhibitor.

VCH-916 free acid(1200133-34-1 free base)

VCH-916 free acid(1200133-34-1 free base)

Copy Product Info
🥰Excellent
Purity: 98.45%
Catalog No. TQ0122LCas No. 914778-92-0
VCH-916 is a novel nonnucleoside HCV NS5B polymerase inhibitor.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$41In StockIn Stock
2 mg$59In StockIn Stock
5 mg$86In StockIn Stock
10 mg$119In StockIn Stock
25 mg$213In StockIn Stock
50 mg$348In StockIn Stock
1 mL x 10 mM (in DMSO)$92In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.45%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

VCH-916 free acid(1200133-34-1 free base) AI Summary
VCH-916 free acid(1200133-34-1 free base) demonstrates antiviral activity, specifically inhibiting SARS-CoV-2-induced cytotoxicity in both Caco-2 and VERO-6 cells. In Caco-2 cells, at a concentration of 10 µM and after 48 hours, the compound showed a 27.07% inhibition rate as determined by high content imaging. However, in VERO-6 cells, it showed a 0.0% inhibition rate at the same concentration and duration. The compound exhibits a low inhibition percentage (-2.517%) for the SARS-CoV-2 3CL-Pro protease at 20 µM, suggesting it may not be effective in inhibiting the protease activity. Additionally, VCH-916 free acid(1200133-34-1 free base) demonstrated inhibitory activity towards human HDAC6 in enzymatic assays, with a higher inhibition percentage (25.78%) when using a commercial peptide substrate compared to a custom peptide substrate (1.43%)..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
VCH-916 is a novel nonnucleoside HCV NS5B polymerase inhibitor.
Chemical Properties
Molecular Weight459.64
FormulaC26H37NO4S
Cas No.914778-92-0
SmilesN(C(=O)[C@@H]1CC[C@@H](C)CC1)(C2=C(C(O)=O)SC(=C2)C=3CCCCC3)[C@@H]4CC[C@@H](OC)CC4
Relative Density.1.20 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 39 mg/mL (84.85 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.1756 mL10.8781 mL21.7562 mL108.7808 mL
5 mM0.4351 mL2.1756 mL4.3512 mL21.7562 mL
10 mM0.2176 mL1.0878 mL2.1756 mL10.8781 mL
20 mM0.1088 mL0.5439 mL1.0878 mL5.4390 mL
50 mM0.0435 mL0.2176 mL0.4351 mL2.1756 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy VCH-916 free acid(1200133-34-1 free base) | purchase VCH-916 free acid(1200133-34-1 free base) | VCH-916 free acid(1200133-34-1 free base) cost | order VCH-916 free acid(1200133-34-1 free base) | VCH-916 free acid(1200133-34-1 free base) chemical structure | VCH-916 free acid(1200133-34-1 free base) formula | VCH-916 free acid(1200133-34-1 free base) molecular weight